Mwanzo1SXP • ETR
add
SCHOTT Pharma AG & Co KgaA
Bei iliyotangulia
€ 25.20
Bei za siku
€ 24.86 - € 25.40
Bei za mwaka
€ 22.22 - € 42.20
Thamani ya kampuni katika soko
3.77B EUR
Wastani wa hisa zilizouzwa
elfu 75.32
Uwiano wa bei na mapato
28.08
Mgao wa faida
0.64%
Ubadilishanaji wa msingi
ETR
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 229.84M | -1.04% |
Matumizi ya uendeshaji wa biashara | 37.28M | 3.28% |
Mapato halisi | 28.89M | -34.94% |
Kiwango cha faida halisi | 12.57 | -34.26% |
Mapato kwa kila hisa | 0.19 | -34.48% |
EBITDA | 57.83M | -7.17% |
Asilimia ya kodi ya mapato | 19.28% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 16.78M | -21.37% |
Jumla ya mali | 1.48B | 19.20% |
Jumla ya dhima | 648.05M | 24.58% |
Jumla ya hisa | 831.59M | — |
hisa zilizosalia | 152.07M | — |
Uwiano wa bei na thamani | 4.62 | — |
Faida inayotokana na mali | 6.72% | — |
Faida inayotokana mtaji | 8.85% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 28.89M | -34.94% |
Pesa kutokana na shughuli | 24.37M | -63.07% |
Pesa kutokana na uwekezaji | -20.96M | 26.74% |
Pesa kutokana na ufadhili | -9.28M | 76.54% |
Mabadiliko halisi ya pesa taslimu | -6.40M | -112.19% |
Mtiririko huru wa pesa | -39.08M | -225.76% |
Kuhusu
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
Ilianzishwa
1 Ago 2022
Tovuti
Wafanyakazi
4,749
